logo
Plus   Neg
Share
Email

DaVita Issues Current 2020 Guidance

DaVita (DVA) said, for fiscal 2020, the company's current outlook for adjusted net income per share from continuing operations is $6.25 to $6.75, compared to prior guidance range of $5.75 to $6.25. Revenue is anticipated in a range of $11.50 billion to $11.70 billion.

Second quarter adjusted earnings per share from continuing operations was $1.95 compared to $1.22, previous year. Consolidated revenues was $2.88 billion compared to $2.84 billion, previous year.

During the second quarter, the company opened a total of 28 new dialysis centers, acquired one center and closed six dialysis centers in the United States. Also, the company acquired three dialysis centers and opened two new dialysis centers outside of the United States during the second quarter.

For the second quarter, total U.S. dialysis treatments were 7,570,908, or an average of 97,063 treatments per day, a per day increase of 0.7% over last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT